Get started
Author

Masahito Minami

Side effects of high-dose interferon therapy for chronic hepatitis C
1996 · Takeshi Okanoue, Shinichi Sakamoto, et al. · Journal of Hepatology · 453
Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients
1999 · Takeshi Okanoue, Yoshito Itoh, et al. · Journal of Hepatology · 236
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
2010 · Hyohun Park, Toshihide Shima, et al. · Journal of Gastroenterology · 197
Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease
2008 · Hironori Mitsuyoshi, Kohichiroh Yasui, et al. · Hepatology Research · 185
Nonalcoholic steatohepatitis and increased risk of chronic kidney disease
2010 · Kohichiroh Yasui, Yoshio Sumida, et al. · Metabolism · 161
Hepatitis B virus DNA in liver, serum, and peripheral blood mononuclear cells after the clearance of serum hepatitis B virus surface antigen
2003 · Yoshiki Murakami, Masahito Minami, et al. · Journal of Medical Virology · 114
Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis
2005 · Masahito Minami, Yukiko Daimon, et al. · Oncogene · 91
Detection of YMDD mutant using a novel sensitive method in chronic liver disease type B patients before and during lamivudine treatment
2002 · Toshihiko Kirishima, Takeshi Okanoue, et al. · Journal of Hepatology · 90
Lower levels of insulin‐like growth factor‐1 standard deviation score are associated with histological severity of non‐alcoholic fatty liver disease
2014 · Yoshio Sumida, Yoshikazu Yonei, et al. · Hepatology Research · 89
Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease
2015 · Yoshio Sumida, Kazuyuki Kanemasa, et al. · Journal of Gastroenterology · 86
Low serum level of hepatitis B core‐related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapy
2007 · Akihiro Matsumoto, Eiji Tanaka, et al. · Hepatology Research · 85
High expression of p300 in HCC predicts shortened overall survival in association with enhanced epithelial mesenchymal transition of HCC cells
2011 · Chihiro Yokomizo, Kanji Yamaguchi, et al. · Cancer Letters · 82
Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study
2009 · Takeshi Okanoue, Yoshito Itoh, et al. · Journal of Gastroenterology · 77
A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase
2005 · Takeshi Okanoue, Akiko Makiyama, et al. · Journal of Hepatology · 77
Premature telomere shortening and impaired regenerative response in hepatocytes of individuals with NAFLD
2005 · Tomoki Nakajima, Michihisa Moriguchi, et al. · Liver International · 73
A Novel PCR Technique UsingAlu-Specific Primers to Identify Unknown Flanking Sequences from the Human Genome
1995 · MASAHITO MINAMI, KARINE POUSSIN, et al. · Genomics · 72
Serum Levels of Soluble Tumor Necrosis Factor Receptors and Effects of Interferon Therapy in Patients With Chronic Hepatitis C Virus Infection
1999 · Yoshito Itoh, Takeshi Okanoue, et al. · The American Journal of Gastroenterology · 68
Role of cell‐cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis C
2006 · Satoru Sekoguchi, Tomoki Nakajima, et al. · Journal of Gastroenterology and Hepatology · 67
Rosuvastatin ameliorates high‐fat and high‐cholesterol diet‐induced nonalcoholic steatohepatitis in rats
2012 · Yoshihisa Okada, Kanji Yamaguchi, et al. · Liver International · 64
Activation of B‐Myb by E2F1 in hepatocellular carcinoma
2008 · Tomoaki Nakajima, Kohichiroh Yasui, et al. · Hepatology Research · 64
ERK5 is a target for gene amplification at 17p11 and promotes cell growth in hepatocellular carcinoma by regulating mitotic entry
2008 · Keika Zen, Kohichiroh Yasui, et al. · Genes Chromosomes and Cancer · 63
Dynamics of Hepatitis C Viremia following Interferon‐α Administration
1998 · Kohichiroh Yasui, Takeshi Okanoue, et al. · The Journal of Infectious Diseases · 62
Serum alanine aminotransferase predicts the histological course of non‐alcoholic steatohepatitis in J apanese patients
2014 · Yuya Seko, Yoshio Sumida, et al. · Hepatology Research · 59
Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma
2011 · Masayasu Jo, Taichiro Nishikawa, et al. · Journal of Gastroenterology · 55
Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C
2007 · Hironori Mitsuyoshi, Yoshito Itoh, et al. · Hepatology Research · 55
Works count: 94
Citation count: 3,678
H-index: 34
I10-index: 53
Year
Topic
Type